Introduction {#Sec1}
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Psychological treatment strategies with relaxation, biofeedback, and/or cognitive therapy have been demonstrated to be effective in patients with migraine or tension-type headache \[[@CR1]--[@CR4]\]. However, not all patients seem to profit from psychological treatment and because of the variable response, interest has focused on the identification of predicting factors influencing treatment outcome. Several authors have proposed that psychological factors, e.g. locus of control (LOC) \[[@CR5], [@CR6]\], catastrophizing \[[@CR7], [@CR8]\], self-efficacy (SE) \[[@CR9]--[@CR11]\], and affective, mood and personality disorders \[[@CR12]--[@CR14]\], may influence both the pain intensity, frequency, headache impact and treatment outcome.

The definition of LOC is a patient's perception of factors influencing the pain, meaning to what extent the patient perceives that internal (own) or external (e.g. significant others or fate) factors are controlling the pain \[[@CR15]\].

For pain patients, LOC has been shown to be related to pain coping style and treatment response and it has been reported that it is the specific pattern of LOC that is essential rather than just the scale with the highest score \[[@CR15]\].

The definition of pain-related SE is a patient's confidence in his or hers abilities to influence the pain. Headache SE has been shown to be related to increased use of positive psychological coping strategies and reduction of anxiety \[[@CR9]\] and to reduce the negative influence of stressful events on headache frequency \[[@CR16]\]. A study of moderators and mediators of treatment outcome for persons with chronic tension-type headache showed, that, the treatment effect measured by headache activity for stress-management therapy alone and combined with antidepressant medication respectively were fully mediated by SE measured by Headache Management Self-Efficacy Scale (HMSE) \[[@CR11]\]. The mediator effect of SE on outcome measured by headache disability was reduced to a third at most when a mood or anxiety disorder was present for both stress-management therapy alone and combined with antidepressant medication even though headache disability was significantly improved by both the treatments \[[@CR11]\]. There was little or no mediator effect of SE for antidepressant medication alone \[[@CR11]\]. Nash and Bach \[[@CR17]\] found that higher SE for headache was associated with lower headache-related disability independent of headache frequency. A study by Rokicki et al. \[[@CR18]\] indicated that the positive outcome of EMG biofeedback training could be related to changes in headache-related SE. The headache management SE scale is a four-item measure with each item matching one of four headache self-management behaviours and Bond et al. \[[@CR10]\] found that a group of patients exposed to a 48 min videotape (content: headache education, effective use of headache medications, cognitive-behavioural stress management and stretching-based muscle relaxation) had significantly higher headache management SE scores than a waiting list group. These results, thus, indicate the importance in behavioral headache treatment of measuring SE for both research and clinical purposes.

A study by Martin et al. \[[@CR5]\] indicated that the Headache-Specific Locus of Control Scale (HSLC) accounted for variance in measures of depression, physical symptoms, disability, catastrophizing, medication use, and treatment preferences not accounted for by a measure of general LOC. These findings point to the need for headache-specific measures of LOC and SE. The HSLC \[[@CR5]\] and HMSE \[[@CR9]\] were selected since they to the best of our knowledge are the only headache-specific measures of the concepts of LOC and SE for which psychometric properties have been established.

Guillemin et al. \[[@CR19]\] propose amongst others that the simple translation of a measure into another language is insufficient to obtain a valid version of the original version due to language and cultural differences. Bullinger et al. \[[@CR20]\] also suggest evaluation of the psychometric properties of the translated version in order to secure cross-culturally comparable translations of surveys.

The aim of the present study was, therefore, to translate the HSLC and HMSE into Danish according to the proposed guidelines and investigate the reliability and validity of the Danish version by comparing findings with the Danish versions with the results from the original studies \[[@CR5], [@CR9]\]. The final version of the Danish translation is presented and applied as a reference material for headache patients in a tertiary referral centre.

Methods {#Sec2}
=======

Patients referred to the Danish Headache Centre (DHC) were diagnosed according to the International Classification Headache Disorders, 2nd edition criteria \[[@CR21]\] by experienced neurologists. Diagnoses were based on a 1-month headache diary, a structured interview, a clinical examination and para clinical tests when necessary. Patients who received a headache diagnosis were consecutively included. The DHC is the only national tertiary headache referral centre and offer multidisciplinary treatment strategies \[[@CR22]\]. The period of inclusion ran from March to June 2003. HSLC, HMSE, symptom check list-90-R (SCL-90 R), the medical outcomes study short-form questionnaire (SF-36), Beck's depression inventory (BDI) and Beck's anxiety inventory (BAI) were administered to the patients by a trained psychologist at their first visit at the DHC. Exclusion criteria were insufficient knowledge of Danish language or the patient lacking time.

The HSLC and HMSE were translated forward and backward using guidelines for cross-cultural adaptation provided by Beaton et al. \[[@CR23]\].

Headache activity was based on the headache frequencies derived from the detailed diagnostic headache diaries \[[@CR22]\]. Medication use was calculated in defined daily doses recommended by WHO \[[@CR24]\] based on the information derived from the headache diaries regarding drugs and doses for three categories (over the counter analgesics, abortive migraine medication, and opiates).

Sick leave due to headache was based on patient's self-reported information prior to the first visit to the clinic.

The HSLC is a 33-item scale (5-point Likert's scale, 1 = strongly disagree to 5 = strongly agree). The scale includes three subscales measuring internal (own) and external \[significant others (health-care professionals) and chance\] LOC. In the original study, it was shown that HSLC predicts medication consumption, psychological consequences of headache episodes (e.g. depression and headache-related disability) and preference for treatment modality even when controlling for headache severity (frequency and intensity) in a sample of college students with recurrent headaches \[[@CR5]\]. A replication study found similar psychometric characteristics for the HSLC subscales when applied to patients at a headache clinic \[[@CR6]\].

The HMSE is a 25-item scale (7-point Likert's scale, 1 = strongly disagree to 7 = strongly agree). The scale measures the SE, i.e. "an individual's perception that they can engage in behaviors that will prevent or manage their recurrent headaches" \[[@CR9]\]. The HMSE score predicts headache-related disability also when controlling for headache severity and HSLC scores \[[@CR9]\].

The SCL-90-R is a 90-item self-report measure of psychological symptom patterns. Items are scored on a 5-point scale (0 = not at all to 4 = extremely) according to how much discomfort the symptom caused during the last week. The original version consists of nine subscales and three summary indices: general symptomatic index (GSI), positive symptom distress level, and positive symptom total. Some cross-cultural validation studies have only found support for the GSI, since all subscales were highly correlated \[[@CR25], [@CR26]\]. A Danish version of the SCL-90-R has shown satisfying reliability and validity \[[@CR27]\].

The SF-36 is a 36-item self-report measure of health-related quality of life. It consists of five scales measuring dysfunction \[physical functioning (PF), role physical (RP), role emotional (RE), social functioning (SF) and bodily pain (BP)\] and three scales measuring negative as well as positive aspects of health \[mental health (MH), vitality (VT) and general health (GH)\]. Furthermore, it is possible to calculate two summary scales: the physical component summary for the four subscales (PF, RP, BP, and GH) primarily measuring physical health, and the mental component summary for the four subscales (VT, SF, RE, and MH) primarily measuring mental health \[[@CR28], [@CR29]\]. On all scales, high scores reflect good health status. The scales differ with regard to number of items, reply possibilities and levels \[[@CR30]\]. The Danish version of the SF-36 has demonstrated good internal consistency and homogeneity \[[@CR31]\] and has been tested in a representative sample (*n* = 4,080) from the general Danish population \[[@CR30]\].

The BDI and the BAI are 21-item self-report measures of depression and anxiety, respectively. The items of both measures are scored on a 4-point scale (0 = not at all to 3 = severely). The BDI measures intensity of depression. It is used worldwide and has been shown to reliably distinguish between depressed and non-depressed individuals \[[@CR32]\]. The BAI is intended to asses the severity of symptoms of anxiety minimally shared with depression \[[@CR33]--[@CR35]\]. Enns et al. \[[@CR36]\] concluded that BDI and BAI assess distinct symptoms of depression and anxiety in clinically depressed samples.

Statistics {#Sec3}
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Internal stability of the HSLC subscales and the HMSE were analysed using Chronbach's α coefficient. The psychometric properties of the HSLC and the HMSE were analysed using Spearman's rank correlation test with 0.05 and 0.01 as significance level (2-tailed). Possible differences across headache diagnoses (MIG, TTH, MIG + TTH, and MOH) and gender were analysed using Mann--Whitney pair-wise tests with 0.05 as significance level (2-tailed). Possible differences between the scores of the sample of patients from a tertiary multidisciplinary headache centre and the scores of a representative sample from the Danish population on the eight subscales of SF-36 and GSI from SCL-90 were analysed using the Student's *t* test with 0.01 as significance level (2-tailed).

Results {#Sec4}
=======

A total of 135 patients were included. The number of patients included in the calculations varies due to missing values. The mean age was 44 years (SD = 13.7, range = 15--75) and 75% were women. The average patient had 20 headache days/month (2--30), consumed 30 standard doses of abortive medicine (analgesics and triptans)/month (0--220), and had five absence days due to headache/month (0--30). There were no gender differences amongst the clinical characteristics. Headache diagnoses and headache data for the different diagnostic groups and basic descriptive statistics for the study measures are shown in Tables [1](#Tab1){ref-type="table"} and [2](#Tab2){ref-type="table"}, respectively. There were no significant differences in scores for HMSE and the three subscales of HSLC across gender and the larger groups of headache diagnoses (MIG, TTH, TTH + MIG, and MOH), except for the MOH patients having significantly (*P* = 0.045) higher scores on the internal LOC scale than patients with both TTH and MIG.Table 1Headache characteristics in 129 consecutive patients (diagnoses, frequency, acute medication, and absence days due to headache)Headache diagnosis*N*FrequencyMedication use (DDD)Absence of workMigraine only137 (3--12)11 (0--32)4 (0--30)TTH only1728 (9--30)22 (0--60)9 (0--30)MIG and TTH4314 (2--30)14 (0--47)2 (0--30)MOH3523 (4--30)62 (0--220)4 (0--30)CPTH724 (9--30)12 (0--50)14 (0--30)CH516 (3--30)12 (0--35)8 (0--30)OTHER^a^924 (7--30)44 (0--135)3 (0--14)Data are presented as mean days/month (ranges in brackets)*TTH* tension-type headache, *MIG* migraine, MOH medication-overuse headache, CPTH chronic post-traumatic headache, *CH* cluster headache, *DDD* defined daily doses^a^Primarily headache attributed to non-vascular intracranial disorder and primary facial painTable 2Descriptive statistics for test scores of the study measures (values from the original study of HMSE \[[@CR9]\] in square brackets \[ \])MeasureMean (SD)RangeNo. of patients^a^HMSE91.7 (25.1) \[110.3 (20.9)\]32--154 \[48--163\]133HSLC Internal34.2 (9.9) \[36.4 (8.0)\]11--55 \[11--52\]135 Chance35.0 (8.9) \[30.9 (8.1)\]15--68 \[13--51\]133 Professional28.4 (7.0) \[28.9 (6.2)\]11--46 \[11--47\]133Headache frequency (days/month)202--30Medication use (DDD/month)300--220BDI8.7 (6.9) \[9.1 (7.0)\]0--31 \[0--35\]133BAI8.0 (7.9)0--32122GSI (SCL-90-R)0.58 (0.47)0.03--2.17135SF-36 PCS40.4 (9.4)12--58135 PF80.3 (21.0)0--100135 GH56.7 (21.8)0--100135 MCS48.4 (9.1)19--64135 SF70.5 (23.9)13--100135*HSLC* Headache-Specific Locus of Control Scale, *HMSE* Headache Management Self-Efficacy Scale, *DDD* defined daily doses, *BDI* Beck's depression inventory, *BAI* Beck's anxiety inventory, *GSI* global severity index, *PCS* physical component score, *PF* physical function, *GH* general health, *MCS* mental component score, *SF* social functioning^a^The number of patients included in the calculations varies due to missing values

The included headache patients scored consistently and significantly (*P* \< 0.005 for all scales) lower than a representative sample from the general Danish population \[[@CR30]\] on all SF-36 subscales (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1SF-36 scores (mean) for headache patients (HP) (*n* = 135) and a Danish population sample (PS) (*n* = 4,080) \[[@CR30]\]. *PF* physical function, *RP* role physical, *BP* bodily pain, *GH* general health, *VT* vitality, *SF* social functioning, *RE* role emotional, *MH* mental health; \**P* \< 0.005

The level of psychological distress as measured by GSI was slightly, but significantly (*P* \< 0.01) higher for the headache patients than for a representative sample from the general Danish population \[[@CR37]\]. 27% of our headache patients reported general distress above the national norm based cut-off score for clinical level of general distress compared with 17.5% in the general Danish population sample \[[@CR37]\].

The HMSE and the subscales of HSLC showed good internal consistency (Cronbach's α ranging from 0.71 to 0.88) and acceptable corrected item-total correlation (Table [3](#Tab3){ref-type="table"}).Table 3Item correlations with scale scores and Cronbach's α for HSLC and HMSE items (values from original studies \[[@CR5], [@CR9]\] in brackets)ScaleItem means varianceCorrected item-total correlationCronbach's αMeanRangeHSLC Health-care professional (*n* = 133)0.520.400.30--0.590.75 (0.88) Internal (*n* = 135)0.130.590.35--0.740.88 (0.86) Chance (*n* = 133)0.320.400.18--0.540.71 (0.84) HMSE (*n* = 135)0.350.42 (0.49)0.058--0.611 (0.27--0.66)0.85 (0.90)*HSLC* Headache-Specific Locus of Control Scale, *HMSE* Headache Management Self-Efficacy Scale

Construct validity of the HMSE and HSLC was assessed by examination of associations between the two scales and measures of health-related quality of life (SF-36) and psychological distress (BDI, BAI, and SCL-90). Intercorrelations for the study measures are presented in Table [4](#Tab4){ref-type="table"}.Table 4Correlation between HSLC and HMSE subscales and other measures (BDI, BAI, SCL-90 GSI), selected SF-36 subscales, and headache frequency (HF)HMSEHSLCHFBDIBAIGSISF-36IntChaProPCSPFGHMCSSFHMSEHSLC Int0.43\*\* Cha−0.58\*\*−0.15 Pro0.010.160.18\*HF−0.160.020.35\*\*−0.11BDI−0.28\*\*0.22\*0.27\*\*0.19\*0.30\*\*BAI−0.180.110.23\*0.26\*\*0.080.60\*\*GSI−0.22\*0.25\*\*0.28\*\*0.180.27\*\*0.79\*\*0.72\*\*SF-36 PCS0.13−0.11−0.19\*−0.08−0.25\*\*−0.34\*\*−0.11−0.70\*\* PF0.18\*−0.10−0.18\*−0.08−0.22\*−0.50\*\*−0.20\*−0.41\*\*0.68\*\* GH0.21\*−0.21−0.29\*\*−0.23\*\*−0.39\*\*−0.59\*\*−0.42\*\*−0.54\*\*0.54\*\*0.54\*\* MCS0.20\*−0.09−0.29\*\*−0.09−0.23\*−0.71\*\*−0.60\*\*−0.70\*\*0.160.35\*\*0.43\*\* SF0.18\*−0.06−0.20\*−0.09−0.13−0.47\*\*−0.26\*\*−0.37\*\*0.55\*\*0.46\*\*0.38\*\*0.51\*\*HSLC Headache-Specific Locus of Control Scale, *HMSE* Headache Management Self-Efficacy Scale, *HF* headache frequency, *BDI* Beck's depression inventory, *BAI* Beck's anxiety inventory, *GSI* global severity index, *PCS* physical component score, *PF* physical function, *GH* general health, *MCS* mental component score, *SF* social functioning\* *P* \< 0.05\*\* *P* \< 0.01 (2-tailed)

High HMSE scores were found to be associated with high scores on internal LOC and low scores on chance LOC. High scores on HMSE had small, but significant correlations with low scores on GSI and BDI, and high scores on PF. The opposite correlations were found for headache frequency. There was no significant correlation between HMSE and headache frequency.

High scores on chance LOC were positively associated with low scores on SF independently of headache frequency.

Discussion {#Sec5}
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The present results suggest that the Danish versions of HMSE and HSLC are both reliable and valid measures of headache-specific SE and LOC with psychometric properties equal to those described in the original reports \[[@CR5], [@CR9]\] and a subsequent study \[[@CR6]\]. The Danish versions of HMSE and HSLC have acceptable values for Cronbach's α and item-total correlations when tested in a sample of headache patients from a tertiary headache centre. We also identified significant correlations between HMSE and HSLC scores and measures of depression, anxiety, general psychopathology, and health-related quality of life corresponding with the original studies \[[@CR5], [@CR9]\] even though different measures were employed. The results thus further support the validity of the concepts of headache-specific SE and LOC across different cultures of Western society.

We found a minor, but significant positive correlation between high headache-specific SE and good PF and low general psychological distress. Headache frequency did not correlate significantly with headache-specific SE, but had minor significant negative correlations with good physical function and low general psychological distress. Patients with high HMSE scores thus have better physical and SF and less symptoms of psychological distress. Similar results are reported in another study of SE and headache \[[@CR16]\].

The reference material presented consists of patients consecutively referred to a tertiary referral headache centre and thus should be representative for patients seen in specialist headache centres. These psychological characteristics can be used as a reference material for the treatment of patients with rare headache diagnoses or headaches difficult to treat as well as baseline values for future treatment studies. The present reference material may, however, not be representative for the general headache population, as they are highly selected and characterised as having refractory or rare headache before they are referred.

Headache data consisted of frequencies only and more precise data (duration and intensity) may yield more information into the correlations between LOC and SE scores and headache activity.

The HMSE and the HSLC may help identifying patients with special needs for non-pharmacological treatment in a multidisciplinary headache centre, since headache-specific SE were found to correlate with general psychological distress, symptoms of depression, and physical function. The concepts of headache-specific SE and LOC may also be helpful in identifying possible mediators or moderators of non-pharmacological headache treatment \[[@CR18]\]. The findings in the present study indicate that the Danish versions of HMSE and the HSLC are reliable and valid measures of the two concepts and we recommend the use of them in future studies of headache-specific LOC and SE.
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